This site uses cookies for learning about our traffic, we store no personal details. ACCEPT COOKIES DECLINE COOKIES What are cookies?
univerge site banner
Original Article | Open Access | Eur. J. Med. Health Sci., 2025; 7(2), 462-472 | doi: 10.34104/ejmhs.025.04620472

Knowledge, Attitude and Practices of People Regarding Dengue Fever and the Concept of Dengue Vaccine in Dhaka, Bangladesh

Aysha Homyra ,
Md. Osman Goni ,
Tanbir Ahammed ,
Swarna Reza ,
Nafisa Nawar Fariha ,
Arifa Rahman ,
Nadia Rahaman ,
Nazia Nazrul Nafsi ,
Md. Monirul Islam* Mail Img Orcid Img

Abstract

Dengue is a vector borne viral disease caused by the flavivirus dengue virus (DENV). About 400 million cases and more than 20,0000 fatalities occurs worldwide each year. Among this over 3 million annual cases of dengue have been reported in Bangladesh. The aim of this study is to evaluate the knowledge, and practices (KAP) regarding dengue virus as well as the study of its awareness of the transmission, prevention, and vaccination in the population of Dhaka, Bangladesh, a city known as the place of dengue outbreaks. For this study a cross-sectional online survey is conducted from October 2023 to January 2024 targeting diverse sociodemographic groups. Results indicated that the majority of respondents (90.64%) were aware of dengue and its vector mosquito their knowledge about the viruses is still very low. Fever were the most commonly recognized symptom which is known by the 97.86% participants and over 73% correctly understand that dengue is not transmitted from person to person. Preventive practices were widely adopted by 89% of respondents using mosquito sprays, repellents, and bed nets. Nearly 39% of participants were uncertain about which medications should be avoided for dengue treatment. In terms of vaccination, 40.94% of respondents strongly supported dengue vaccination while a significant minority (15.98%) held neutral views. Despite high awareness and preventive behaviors, a gap remains in detailed knowledge about dengue transmission and specific preventive measures. These findings highlight the need for targeted public health campaigns to enhance community understanding and reduce dengue incidence in Dhaka.

Introduction

Division of Molecular Diagnosis and Clinical Genetics Research, BioIcon Dengue is a severe and widespread disease transmitted by female Aedes mosquitoes, particularly the Aedes aegypti species.  It is caused by any of the four serotypes (DENV1, DENV2, DENV3, or DENV4) of the dengue virus, genus Flavivirus from the family of Flaviviridae and is transferred among humans (Jansen & Beebe, 2010; Trivedi & Chakravarty, 2022). Each year, there are around 400 million cases of dengue worldwide, resulting in over 22,000 deaths (Roy & Bhattacharjee, 2021). Though dengue is prevalent in Asia, South America and African countries, nearly 75% of the current global disease burden due to dengue viruses is reported in the Southeast Asia (SEA) region together with Western Pacific (WP) region (Singh et al., 2017). Since 2000, Bangladesh has had recurrent occurrences of dengue outbreaks (Bhowmik et al., 2023; Mamun et al., 2019) and it has experienced 1393 deaths from 277 801 dengue cases in 2023 (Sharif et al., 2024). 

Aedes aegypti, the primary carrier of the dengue virus, reproduces in or near houses by depositing eggs in both artificial and natural water containers. Individuals who remain at home, such as women and children, are more vulnerable to infection during the daytime, as the mosquito requires 8 to 12 days of incubation before it can transmit the virus to susceptible individuals (Scott et al., 2000) (Morsy, 2018). The transmission of DENV from the human host to mosquitoes necessitates the synchronization of various biological variables in both time and location (Carrington & Simmons, 2014). In natural conditions, a susceptible mosquito can only contract DENV after consuming blood from a viremic person. Viremic blood enters the mosquito midgut, where extracellular virus attaches to unidentified receptors on the epithelial surface (Carrington & Simmons, 2014) (Ponlawat & Harrington, 2005). If the virus infects and replicates in midgut epithelial cells, additional virus progeny are spread into the hemocoel (a body cavity that houses either blood or hemolymph). After a significant amount of virus replication takes place in the salivary glands, the virus can be transmitted to a new host through the saliva of the infected mosquito during its next probing or feeding episode (Carrington & Simmons, 2014). Fever, Headache, Nausea, Vomiting, rashes and aches are some of the common symptoms of dengue soon after infection while warning signs of dengue includes abdominal pain, clinical fluid accumulation, mucosal bleed, liver enlargement (>2 cm), and lethargy. In severe cases dengue patients can experience shock, severe bleeding and impaired consciousness (Htun et al., 2021) (Deshwal et al., 2015). Currently, a variety of conventional methods are employed for the detection of Dengue virus (DENV) (Mohammad et al., 2021; Kabir et al., 2021). 

These include NS1-based antigen testing, which identifies the presence of the non-structural protein 1 (NS1) produced during viral replication (Zhang et al., 2014). Additionally, IgM/IgG antibody testing is widely used to detect the bodys immune response to the virus. Another crucial method is Polymerase Chain Reaction (PCR), a molecular technique that amplifies and detects the viral RNA, providing a highly specific and sensitive approach to DENV diagnosis (Vongsouvath et al., 2016). These testing methods are integral to the effective management and control of dengue infections. Currently, there are no targeted therapies or remedies available for the treatment of dengue. Present treatment alternatives are primarily palliative, with the objective of mitigating the consequences and intensity of symptoms. Currently, the US Food and Drug Administration (FDA) has not approved any medications specifically for treating dengue (Harapan et al., 2020). Multiple potential therapeutic agents for treating dengue, which focus on either the viral or host components, have undergone clinical trials. These include carbazochrome sodium sulfonate, which aims to prevent capillary leakage (Tassniyom et al., 1997), oral prednisolone, which acts as an anti-inflammatory agent (Tam et al., 2012), and lovastatin (a statin), which has both anti-DENV and anti-inflammatory effects on the endothelium (Martínez-Gutierrez et al., 2011). The use of paracetamol, ibuprofen, acetylsalicylic acid (aspirin), and other non-steroidal anti-inflammatory drugs is not recommended for dengue fever due to their limited pain-relieving effects, which can worsen gastritis or bleeding (Deen & von Seidlein, 2019). The consumption of certain fruits, such as papaya, apples, and guava, has been demonstrated to be beneficial for dengue patients, particularly in augmenting platelet levels. These fruits, rich in essential nutrients and bioactive compounds, play a supportive role in the clinical management of dengue, potentially mitigating the risk of severe thrombocytopenia and enhancing patient recovery outcomes (Uddin et al., 2022; Deshpande et al., 2021). 

A minimum of seven DENV vaccines have undergone various stages of clinical testing; yet, only three of them (Dengvaxia®, TV003, and TAK-003) have demonstrated encouraging outcomes. Currently, the only vaccine that has been authorized for clinical use in certain countries is a live attenuated vaccine called chimeric yellow fever 17D-tetravalent dengue vaccine (CYD-TDV) (Huang et al., 2021). To achieve and maintain a decrease in dengue-related morbidity, effective vector control strategies are essential. The primary strategy for controlling dengue vectors has been source reduction, which involves getting rid of any containers that provide an ideal environment for oviposition and the growth of the aquatic stages. Insecticides can be used to kill the aquatic stages or lids or coverings can be placed on containers to do this (Organization & others, 2012). This study aimed to assess the knowledge, attitudes, and practices of participants from diverse sociodemographic backgrounds regarding dengue, its vector, prevention methods, and vaccination

Materials and Methods

Study Setting

A community-based cross-sectional study was conducted among students and professionals in Dhaka (23.6850° N, 90.4152° E), the capital of Bangladesh (Fig. 1). Dhaka is centrally positioned in the country and is known as a hotspot for the spread of dengue fever and the number of people affected (Bonna et al., 2023). The population of the area is around 44,215,107, with a significant population density of 2,200 individuals per square kilometer. The presence of indoor and outdoor receptacles that collect stagnant water between the tall and short residential buildings could be a significant factor contributing to the high number of dengue cases in this study location (Mutsuddy et al., 2019).  

Fig. 1: Map of the Study Area in Dhaka (ArcMap).

Participants and Sample Size

513 randomly selected replies were obtained in Dhaka, Bangladesh, between October 2023 and January 2024 from men and women of diverse ages, marital statuses, and sociodemographic backgrounds. The online survey was intended to be descriptive and cross-sectional in nature. Social media users (Facebook, WhatsApp, Instagram, Gmail, and so on) were included in the survey and completed this form; some of the participants did the survey through group discussions, observation, and other means. Both people who refused to participate in the study and those who submitted incomplete questionnaires were excluded from the study. The participation was entirely voluntary and anonymous, and there were no incentives or other types of payment given to the participants.

Knowledge, attitude, and practice questionnaire 

The researchers utilized a self-administered close-ended questionnaire as a tool to assess the residents initial knowledge, attitude, and practice (KAP). The study team produced the questionnaire using a new and modernized pattern that is well-suited for the Bangladeshi community. The questionnaire consists of four sections. Section A pertains to the sociodemographic data, which encompasses the fundamental information of the participants. Section B covers the fundamental understanding of the participants regarding dengue illness and its vector. Sections C and D are dedicated to knowledge of participants on the prevention and vaccination of dengue.

Statistical analysis

All categorical variables, such as participant demographics, professional background, and opinions on genetic testing, were presented as frequencies and percentages. Data analysis was conducted using R studio, SPSS version 25 (SPSS Inc., Chicago, IL) and Microsoft Excel. Descriptive statistics were used to calculate proportions. Spearmans correlation test was performed to assess the relationship between willingness to receive vaccines with varying efficacies. All statistical tests were conducted with a significance threshold of 5%, and the correlation coefficient (ρ) along with the corresponding 95% confidence intervals (CI) were reported where applicable.

Results

Sociodemographic profile of study population

Table 1: Sociodemographic characteristics of study population.

Out of the 513 distributed questionnaires, the gender distribution was nearly balanced, with 47.56% male and 52.44% female respondents. The majority of participants fell within the 18-26 age range (71.53%), while only a small fraction was under 18 years old (0.58%) (Table 1). A significant proportion of participants resided in urban areas (82.26%), compared to those from semi-urban areas (13.06%) and rural regions (4.68%). Over half of the respondents (58.09%) held undergraduate degrees, and 18.01% had completed postgraduate education, whereas only 3.90% had received education up to the S.S.C/O level. Despite the high level of educational attainment, the majority were unemployed students (63.74%). Among employed respondents, 18.13% worked in the private sector, while the proportions of government employees and homemakers were approximately 4%. Respondents with other occupations accounted for 2.92%.

Knowledge about dengue and its vector
Table 2 provides a detailed summary of respondents knowledge regarding dengue and its vectors. A significant majority (90.64%) were aware of dengue, with the internet being the primary source of information, accounting for over 30% of responses. Friends and family, along with TV/radio, were the next most common sources, contributing 20.86% and 22.61% respectively. Information obtained from schools (7.60%), newspapers (9.36%), and health workers (7.21%) showed relatively similar contributions.

Table 2: General Assumption about Dengue fever and Mosquitoes among respondents.
Notably, 91.71% of respondents correctly identified that dengue is transmitted through mosquito bites. However, there was a lack of awareness regarding the virus types, with nearly half (44.83%) of the respondents unaware of this aspect. Only 147 respondents (28.65%) out of a total of 513 demonstrated a clear understanding of the different virus types.

Regarding the symptoms of dengue, a high-grade fever was the most frequently observed symptom, reported by 97.86% of the study participants. This was followed by reports of headache (76.80%), pain (73.88%), vomiting (65.50%), nausea (64.32%), rash (63.35%), and aches (41.52%). The majority of respondents (79.92%) believed that Aedes mosquitoes primarily breed in standing water during the rainy season (July-August). Approximately 88.50% of respondents considered dengue to be treatable. When asked about the use of specific medications, 40.93% of participants believed aspirin should be prohibited, followed by paracetamol (10.52%) and ibuprofen (7.99%). However, a significant portion of respondents (38.60%) lacked knowledge about which medications should be avoided. Only 1.94% of respondents indicated that dengue patients should avoid Nimesulide. Furthermore, 73.68% of participants correctly understood that dengue does not transmit from person to person, compared to 22.02% who held the opposite view. A negligible percentage of respondents (4.28%) had no opinion on this matter.

Knowledge and practices toward dengue diagnosis and prevention
Although the majority of participants (66.47%) did not engage in health education related to dengue, they demonstrated satisfactory knowledge of dengue diagnosis and prevention (Table 3). A significant portion of respondents (85.38%) believed that dengue diagnosis should be conducted in a hospital or clinic, rather than through medical scans (1.17%), assessment of medical history (0.19%), or the use of home test kits (2.72%). Additionally, 6.23% of participants recognized the importance of monitoring clinical signs and symptoms, such as sore throat, cough, and fever. A substantial proportion of participants (81.87%) were aware of the beneficial effects of papaya for dengue patients. Moreover, nearly 60% of participants believed that dengue patients sometimes require hospitalization, compared to 30.02% who thought that hospitalization should be mandatory. Regarding dengue prevention, 42.69% of participants reported that cleaning water-filled containers, coolers, and ditches around the house and workplace should be performed every alternate day. Some participants preferred weekly cleaning (33.72%), while others opted for fortnightly (7.60%) or monthly (8.19%) cleaning. Mosquito vector control was commonly practiced among participants, with 89.28% using mosquito sprays and repellents, followed by preventing standing water in and around the house (89.08%), and using bed nets, window, and door screens (88.89%). Other preventive measures included preventing garbage accumulation (78.36%), regular cleaning of coolers (77.39%), and wearing full-sleeved clothing (72.51%). Additionally, 60.23% of respondents emphasized the need for a combination of these preventive measures.
 
Table 3: Opinion and practices towards dengue fever diagnosis and prevention.
Opinion about the vaccination dengue
The majority of respondents demonstrated strong support for dengue vaccination, with 40.94% and 35.67% strongly agreeing and agreeing, respectively, on its importance for prevention. A small minority expressed disagreement, with 5.65% disagreeing and 1.75% strongly disagreeing Table 4.

Table 4: Opinion about dengue fever vaccination among the participants.

Notably, 15.98% of respondents remained neutral in their views on the necessity of dengue vaccination. Despite nearly half of the population (47.17%) being unaware of the availability of a dengue vaccine, a significant majority (85.58%) expressed confidence that a vaccine could cure dengue. Approximately 65% of respondents believed or strongly believed in the potential of the dengue vaccine to increase immunity, and over 60% of respondents believed that all registered vaccines are medically safe. Most participants placed trust in vaccines prescribed by doctors and believed that pharmaceutical companies produce safe and effective vaccines. Additionally, they indicated a readiness to accept vaccines approved in Bangladesh. A considerable proportion of the study population (82.46%) supported the implementation of a national vaccination program, and 43.08% were willing to purchase the vaccine if available in private hospitals. The acceptance rates for vaccines with low side effects and 50% and 75% efficacy were 19.69%, 49.18%, and 69.01%, respectively. There was a significant positive correlation (r = 0.9937) found between vaccination desire and vaccine effectiveness (p < 0.05).

Discussion

Dengue is the world most rapidly spreading viral infectious illness spread by mosquitoes, with a high rate of morbidity and mortality. Significant advancements in the understanding of its epidemiology, including risk factors, control and prevention strategies, illness load and distributions, have been accomplished in recent decades (Jing & Wang, 2019). Bangladesh is sporadically facing the pandemic from the year of 1964 (Sharmin et al., 2015) and its outbreak still remain in recent years (2019-2023). It also experienced more than 10million to 3.2 million confirmed cases with less or more than 0.5% fatalities (Roney et al., 2024). This study performed an online survey among 513 of nearly equal portion of male and female in Dhaka which is considered to be dengue hotspot to check their knowledge, attitudes and practices towards dengue, vectors and vaccination and tried to confirm their willingness of accepting different vaccines with different efficacy. Major chunk of the study population (almost 80%) received college and graduate education and majority (82.26%) of them were native city dwellers albeit many (63.74%) of them remained unemployed and the internet, as predicted, was the greatest knowledge source (32.36%) compared to other platforms such as newspapers, radio, TV, schools, and family. The participants knew that dengue can cause fever, headaches, nausea, vomiting, rash, aches, and pains, as well as common breeding locations and seasons. However, some participants were still ignorant of the different types of dengue viruses, how they spread, whether or not they can be treated, which medications are best for treating dengue, and which ones should be avoided.

Fig. 2: correlation between vaccine efficacy and eagerness to get vaccinated.

The majority of respondents (66.47%) did not actively participate in the dengue health program, although they did follow appropriate hygiene practices regarding water-filled containers, coolers, and ditches surrounding the home and office, as well as the hospitalization requirements and dengue diagnosis procedures. Additionally, they were well-versed in the prevention of dengue, including the use of insect repellents and sprays, bed nets, window and door screens, full-sleeve clothing, regular cooler cleaning, avoiding garbage collection, and the advantages of eating papaya over most other fruits like bananas, apples, and mangos during dengue season. This survey also demonstrated the value of dengue vaccination, since most participants (82.46%) believed that dengue could be cured through immunization and that vaccination should be provided free of charge across the country. They also trust Bangladeshi pharmaceutical companies to provide safe and effective vaccines, and they are willing to purchase even if it is only available in private hospitals. This shows how serious dengue is in Bangladesh and how urgently effective vaccines are needed. Doctors will recommend the safest vaccine for their patients. Remarkably, a strong positive connection (r = 0.9937) was observed between the effectiveness of vaccines and the desire to be vaccinated (p < 0.05), indicating the population under study has the discriminatory potential to select vaccines that work (Fig. 2). 

Conclusion

Bangladesh has a very high dengue incidence rate, with Dhaka ranking highest due to factors like a large population living in a small area, environ-mental pollution, ignorance, and a lack of regulations and implementation. The general publics understanding of dengue fever in Dhaka is adequate but still has to be increased through educational initiatives in hospitals, schools, and universities. In reality, this survey only included educated people; nonetheless, Dhaka is home to a sizable community of uneducated people who are ignorant of the scientific way of life. Social professionals, the government, and individuals all need to raise public knowledge of dengue fever from all angles.

Author Contributions

The authors have contributed to the data collecting, analysis, and manuscript writing processes. Md. Monirul Islam gave the work a thorough review and offered insightful comments. All authors reviewed and approved the final manuscript.

Acknowledgement

The studys participants have our sincere gratitude, the authors write. Additionally, they would like to thank the distinguished professors from different universities who were instrumental in motivating their students to participate in this study in Bangladesh.

Conflict of Interests

Every author declared that they have no conflicting interests.

Supplemental Materials:

| 4.00 KB

UniversePG does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted UniversePG a non-exclusive, worldwide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

Article References:

  1. Bhowmik, K. K., Ferdous, J., Baral, P. K., & Islam, M. S. (2023). Recent outbreak of dengue in Bangladesh: A threat to public health. Health Science Reports, 6(4), 1–8. https://doi.org/10.1002/hsr2.1210 
  2. Carrington, L. B., & Simmons, C. P. (2014). Human to mosquito transmission of dengue viruses. Frontiers in Immunology, 5(JUN), 1–8. https://doi.org/10.3389/fimmu.2014.00290 
  3. Deen, J., & von Seidlein, L. (2019). Paracetamol for dengue fever: no benefit and potential harm? The Lancet Global Health, 7(5), e552–e553. https://doi.org/10.1016/S2214-109X(19)30157-3    
  4. Deshpande, M., Singh Parihar, P., & Agarwal, H. (2021). Benefits of Papaya Fruit and its leaves to Treat Malaria or Dengue and Various Other Uses for Human Health Meesha Deshpande (Guide). International Research J. of Engineering and Technology, 8(June), 3460–3467. 
  5. Deshwal, R., Qureshi, M. I., Singh, R., & others. (2015). Clinical and laboratory profile of dengue fever. J Assoc Physicians India, 63(12), 30–32.
  6. Harapan, H., Michie, A., Sasmono, R. T., & Imrie, A. (2020). Dengue : A Minireview. 1, 1–35.
  7. Htun, T. P., Xiong, Z., & Pang, J. (2021). Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis. Emerging Microbes and Infections, 10(1), 1116–1128. https://doi.org/10.1080/22221751.2021.1935327 
  8. Jansen, C. C., & Beebe, N. W. (2010). The dengue vector Aedes aegypti: what comes next. Microbes and Infection, 12(4), 272–279. https://doi.org/10.1016/j.micinf.2009.12.011 
  9. Jing, Q., & Wang, M. (2019). Dengue epidemiology. Global Health J., 3(2), 37–45. https://doi.org/10.1016/j.glohj.2019.06.002 
  10. Kabir, M. A., Zilouchian, H., & Asghar, W. (2021). Dengue detection: Advances in diagnostic tools from conventional technology to point of care. Biosensors, 11(7), 1–28. https://doi.org/10.3390/bios11070206 
  11. Mamun, M. A., Misti, J. M., & Gozal, D. (2019). The dengue epidemic in Bangladesh: risk factors and actionable items. The Lancet, 394(10215), 2149–2150. https://doi.org/10.1016/S0140-6736(19)32524-3 
  12. Mohammad Zakerin Abedin et al. (2021): Analysis of the Dengue Infection, Occurrence and Hematological Profile of Dengue Patients in Dhaka City, J Microbiol Pathol. 5, 115. 
  13. Morsy, T. A. (2018). Aedes aegypti and dengue virus infections. J. of the Egyptian Society of Parasitology, 48(1), 183–196.
  14. Mutsuddy, P., Tahmina Jhora, & Dhiman, S. (2019). Dengue Situation in Bangladesh: An Epidemiological Shift in terms of Morbidity and Mortality. Canadian J. of Infectious Diseases and Medical Microbiology, 2019, 2017–2022. https://doi.org/10.1155/2019/3516284 
  15. Organization, W. H., & others. (2012). Global strategy for dengue prevention and control 2012-2020.
  16. Ponlawat, A., & Harrington, L. C. (2005). Blood feeding patterns of Aedes aegypti and Aedes albopictus in Thailand. J. of Medical Entomology, 42(5), 844–849. https://doi.org/10.1093/jmedent/42.5.844 
  17. Roney, M., Huq, A. M., & Aluwi, M. F. F. M. (2024). Record dengue deaths in Bangladesh as disease patterns change. Acta Tropica, 256(May). https://doi.org/10.1016/j.actatropica.2024.107256 
  18. Roy, S. K., & Bhattacharjee, S. (2021). Dengue virus: Epidemiology, biology, and disease aetiology. Canadian J. of Microbiology, 67(10), 687–702. https://doi.org/10.1139/cjm-2020-0572 
  19. Scott, T. W., Morrison, A. C., & Edman, J. D. (2000). Longitudinal studies of Aedes aegypti (Diptera: Culicidae) in Thailand and Puerto Rico: Population dynamics. J. of Medical Entomology, 37(1), 77–88. https://doi.org/10.1603/0022-2585-37.1.77 
  20. Sharif, N., Sharif, N., & Dey, S. K. (2024). The Epidemiologic and Clinical Characteristics of the 2023 Dengue Outbreak in Bangladesh. Open Forum Infectious Diseases, 11(2), 1–4. https://doi.org/10.1093/ofid/ofae066 
  21. Sharmin, S., Viennet, E., & Harley, D. (2015). The emergence of dengue in Bangladesh: Epidemiology, challenges and future disease risk. Transactions of the Royal Society of Tropical Medicine and Hygiene, 109(10), 619–627. https://doi.org/10.1093/trstmh/trv067 
  22. Singh, M., Chakraborty, A., & Kumar, A. (2017). The epidemiology of dengue viral infection in developing countries: A systematic review. J. of Health Research and Reviews (In Developing Countries), 4(3), 104–107.
  23. Tam, D. T. H., Ngoc, T. V.,  & Wills, B. A. (2012). Effects of short-course oral corticosteroid therapy in early dengue infection in vietnamese patients: A randomized, placebo-controlled trial. Clinical Infectious Diseases, 55(9), 1216–1224. https://doi.org/10.1093/cid/cis655 
  24. Tassniyom, S., Vasanawathana, S., Nisalak, A., & Chirawatkul, A. (1997). Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: A randomized, controlled trial. J. of Pediatrics, 131(4), 525–528. https://doi.org/10.1016/S0022-3476(97)70055-6  
  25. Trivedi, S., & Chakravarty, A. (2022). Neurological Complications of Dengue Fever. Current Neurology and Neuroscience Reports, 22(8), 515–529. https://doi.org/10.1007/s11910-022-01213-7 
  26. Uddin ME, Sultana S, and Mahmud S. (2022). Non-biotech students perception of biotechnology and its applications in a university theology faculty students: a brief survey study. Int. J. Agric. Vet. Sci., 4(6), 116-129. https://doi.org/10.34104/ijavs.022.01160129 
  27. Vongsouvath, M., Phommasone, K., & Dubot-Pérès, A. (2016). Using Rapid Diagnostic Tests as a Source of Viral RNA for Dengue Serotyping by RT-PCR - A Novel Epidemiological Tool. PLoS Neglected Tropical Diseases, 10(5), 1–15. https://doi.org/10.1371/journal.pntd.0004704 
  28. Zhang, H., Li, W., & Zhou, Y. (2014). NS1-based tests with diagnostic utility for confirming dengue infection: A meta-analysis. Inter J. of Infectious Diseases, 26, 57–66. https://doi.org/10.1016/j.ijid.2014.02.002 

Article Info:

Academic Editor 

Dr. Phelipe Magalhães Duarte, Professor, Department of Veterinary, Faculty of Biological and Health Sciences, University of Cuiabá, Mato Grosso, Brazil

Received

February 10, 2025

Accepted

March 12, 2025

Published

March 19, 2025

Article DOI: 10.34104/ejmhs.025.04620472

Corresponding author

Cite this article

Homyra A, Goni MS, Ahammed T, Reza S, Fariha NN, Rahman A, Rahaman N, Nafsi NN, and  Islam MM. (2025).  Knowledge, attitude and practices of people regarding dengue fever and the concept of dengue vaccine in Dhaka, Bangladesh, Eur. J. Med. Health Sci., 7(3), 462-472. https://doi.org/10.34104/ejmhs.025.04620472

 

Views
115
Download
17
Citations
Badge Img
Share